RFA #: 1212030210
|Icahn School of Medicine at Mount Sinai||Ronald Hoffmann||$8,782,529||Commercialization of Valproic Acid Expanded Cord Blood Stem Cells as Allogeneic Grafts for Adults with Refractory Hematological Malignancies|
|Roswell Park Cancer Institute||Kunle Odunsi||$11,922,885||Programing Hematopoetic Stem Cells for Long-Term Targeted T Cell Therapy of Patients with Relapsed Ovarian Cancer|
|Weill Cornell Medical College||Shahin Rafii||$15,717,575||Vascular Niche Platform to Expand Hematopoietic Stem and Progenitor Cells Engineered to Cure Sickle Cell Disease|
Please visit the Developing Cures page for more information.